10.3 Controlled Substance Inventories & BNE Registration

Controlled Substance Inventories & BNE Registration

New York's controlled-substance licensing structure runs on a second track, entirely separate from ordinary pharmacy licensure. The New York State Education Department (NYSED) Board of Pharmacy licenses pharmacists and registers pharmacy premises under Education Law Article 137. The Department of Health (DOH) Bureau of Narcotic Enforcement (BNE) separately licenses the activity of manufacturing, distributing, dispensing, researching, or otherwise handling controlled substances under Public Health Law (PHL) Article 33 and its implementing regulation, 10 NYCRR Part 80. The MPJE tests both halves, and candidates frequently mix them up — knowing which agency governs which requirement is itself a testable point.

Who Actually Needs a BNE Controlled-Substance License

BNE licensure is organized into numbered classes covering the full controlled-substance supply chain: Class 1/1A (Manufacturer, in-state/out-of-state), Class 2/2A (Distributor), Class 2R (Reverse Distributor), Class 3 (Institutional Dispenser), Class 3A (Institutional Dispenser, Limited), Class 3C (Emergency Medical Services), Class 4/4A (Researcher), Class 5 (Instructional Activities), Class 7 (Research/Instructional, Schedule I), Class 8 (Analytical Laboratory), Class 9/9A (Importer), and Class 10/10A (Exporter).

A key nuance the MPJE expects you to know: an ordinary retail/community pharmacy dispensing controlled substances against a valid prescription does not, by itself, need a separate BNE controlled-substance license. Its authority to handle Schedule II–V drugs comes from its NYSED Board of Pharmacy pharmacy registration plus its own federal DEA registration — everyday retail dispensing is not one of the BNE license classes. BNE licensure instead attaches to higher-risk, non-retail activities: manufacturing, wholesale distribution, and — critically — institutional dispensing:

• Class 3 (Institutional Dispenser) covers hospitals and clinics operating under an Article 28 operating certificate; the application requires a copy of that operating certificate, the facility's NYS BOP pharmacy registration, and its DEA registration as a Hospital/Clinic.
• Class 3A (Institutional Dispenser, Limited) covers nursing homes, adult care facilities, and other residential health care facilities (RHCFs) under Title 18 NYCRR Parts 487, 488, and 490 that administer — but do not independently stock and dispense — controlled substances to residents, always pursuant to a prescription written by a practitioner and filled by a registered pharmacy.
• Class 11 (Pharmacy – Registered Community Pharmacy for ADS Operations) is the one scenario where a retail/community pharmacy itself needs BNE licensure: when that pharmacy installs and operates an Automated Dispensing System (ADS) inside a Class 3A-licensed RHCF. Class 11 policies must cap each emergency medication kit ("E-kit") at no more than ten different controlled substances in unit-dose packaging, of which no more than three may be injectable, and each E-kit must have a 24-hour lock-out feature after initial use. Class 11 carries no license fee.

DEA Registration Interplay

All BNE license classes except Class 3A must also hold the equivalent federal DEA registration, issued to the same licensed location, before engaging in any controlled-substance activity; a copy of the DEA registration must be forwarded to BNE's licensing unit upon receipt. Class 3A is the sole exemption because an Institutional Dispenser, Limited does not independently stock bulk controlled substances — it administers doses that were already dispensed by a DEA-registered pharmacy against a practitioner's prescription.

License Mechanics: Application, Validity, Renewal

All BNE applications and renewals — new, change, renewal, or amendment — use Form DOH-4330, e-mailed to bnelicensing@health.ny.gov. A BNE license is valid for two years from its effective date. BNE sends a renewal reminder roughly 90 days before expiration, but the licensee remains legally responsible for filing a complete, satisfactory renewal on time. Renewal applications may be submitted up to 90 days before expiration and should be sent 30–45 days before the current expiration date; if a license has been expired for more than 60 days, the holder is no longer eligible to renew and must file as a New applicant — no extensions of the expiration date are granted.

Fees scale with risk class: Manufacturer/Distributor/Importer/Exporter classes (1, 1A, 2, 2A, 9, 9A, 10, 10A) run $1,200 new / $250 renewal; Institutional Dispenser classes (3, 3A) run $100 new / no renewal fee; Researcher/Instructional/Laboratory classes (4, 5, 7, 8) run $40 new / $20 renewal; and Class 2R (Reverse Distributor) and Class 11 (Pharmacy ADS) carry no fee at all. New York State, county, and municipal agencies are fee-exempt as applicants, but their individual employees are not.

Biennial Inventory — 10 NYCRR §§80.111–80.112

Section 80.111 designates the controlled substances listed in PHL §3306 as "inventory required substances." Section 80.112 then requires every manufacturer, distributor, importer, exporter, institutional dispenser, researcher, instructional/maintenance-treatment program, analytical laboratory, practitioner, and pharmacy possessing, controlling, selling, prescribing, administering, dispensing, or compounding controlled substances to prepare and maintain a physical inventory as of May 1, 1975, and every two years thereafter. The rule requires a separate entry for each drug and package size/quantity on hand as of the inventory date.

The practical payoff for a working pharmacy: §80.112(a) expressly states that maintaining a biennial inventory prepared in compliance with federal statute and regulation "shall be deemed compliance" with the New York rule. Because the federal biennial inventory under 21 CFR 1304.11 may be taken on any date within two years of the prior inventory (not locked to a fixed May 1/odd-year date), a pharmacy that keeps its DEA biennial current automatically satisfies New York's §80.112 as well — it does not need to separately chase the historical May 1 anchor date. The inventory copy must then be retained with the pharmacy's other controlled-substance records and kept available for inspection for at least five years (§80.112(b)) — longer than the federal two-year invoice-retention default, and consistent with the five-year pattern set elsewhere in New York pharmacy recordkeeping (8 NYCRR §63.6).

Duty to Report Loss, Theft, or Diversion

Section 80.110 requires every PHL Article 33 licensee to promptly notify DOH of (a) each incident or alleged incident of theft, loss, or possible diversion of controlled substances, filed on the department's designated form, and (b) any legal or administrative proceeding alleging a violation of the federal Controlled Substances Act or another state's controlled-substance law. A copy of the loss/theft report must be retained for five years under PHL §3370 and §80.110.

License Classes at a Glance

Exam Traps

• "Does every New York pharmacy need its own BNE controlled-substance license?" — No; ordinary retail dispensing runs on the pharmacy's NYSED registration plus its DEA registration. BNE licensure is for manufacturers, distributors, institutional dispensers, and the specific Class 11 ADS-in-RHCF scenario.
• "Which BNE class is exempt from the federal DEA registration requirement?" — Class 3A (Institutional Dispenser, Limited) only; every other class must hold the equivalent DEA registration.
• "On what date must New York's biennial controlled-substance inventory be taken?" — There is no fixed date in practice: complying with the federal biennial inventory (any date within a two-year window) is deemed to satisfy 10 NYCRR §80.112.
• "How long must the biennial inventory record be kept on file?" — At least five years, under §80.112(b) — not the federal two-year invoice minimum.